These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 32640948)

  • 1. Modifiable Risk Factors Associated With Moyamoya Disease: A Case-Control Study.
    Ge P; Zhang Q; Ye X; Liu X; Deng X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
    Stroke; 2020 Aug; 51(8):2472-2479. PubMed ID: 32640948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperhomocysteinemia is a risk factor for postoperative ischemia in adult patients with moyamoya disease.
    Li J; Ge P; Zhang Q; Lin F; Wang R; Zhang Y; Zhang D; Wang W; Zhao J
    Neurosurg Rev; 2021 Oct; 44(5):2913-2921. PubMed ID: 33506361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of moyamoya disease with thyroid autoantibodies and thyroid function: a case-control study and meta-analysis.
    Lei C; Wu B; Ma Z; Zhang S; Liu M
    Eur J Neurol; 2014 Jul; 21(7):996-1001. PubMed ID: 24684272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of thyroid autoantibodies with moyamoya-type cerebrovascular disease: a prospective study.
    Kim SJ; Heo KG; Shin HY; Bang OY; Kim GM; Chung CS; Kim KH; Jeon P; Kim JS; Hong SC; Lee KH
    Stroke; 2010 Jan; 41(1):173-6. PubMed ID: 19926842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperhomocysteinemia Independently Associated with Adult Moyamoya Disease: Hospital Based Study of 237 Patients.
    Zhang Y; Fu X; Zeng X; Xu J; Liu H; Li X; Gao Q
    Turk Neurosurg; 2021; 31(2):167-172. PubMed ID: 33216330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased prevalence of autoimmune disease in patients with unilateral compared with bilateral moyamoya disease.
    Chen JB; Liu Y; Zhou LX; Sun H; He M; You C
    J Neurosurg; 2016 May; 124(5):1215-20. PubMed ID: 26406790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Expression of Vascular Endothelial Growth Factor-A
    Jiang H; Toscano JF; Schiraldi M; Song SS; Schlick KH; Dumitrascu OM; Liou R; Lyden PD; Pan J; Zhan R; Saver JL; Gonzalez NR
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):360-368. PubMed ID: 30392834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective evaluation of the diagnostic value of plasma apelin 12 levels for differentiating patients with moyamoya and intracranial atherosclerotic diseases.
    Hu W; Jiang W; Ye L; Tian Y; Shen B; Wang K
    Sci Rep; 2017 Jul; 7(1):5452. PubMed ID: 28710384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Hyperthyroidism and Thyroid Autoantibodies with Moyamoya Disease and Its Stroke Event: A Population-based Case-control Study and Meta-analysis.
    Ahn JH; Jeon JP; Kim JE; Ha EJ; Cho WS; Park YJ; Cho NH; Choi HS; Kang HS; Son YJ; Bang JS; Oh CW
    Neurol Med Chir (Tokyo); 2018 Mar; 58(3):116-123. PubMed ID: 29353860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors for adult patients with hemorrhagic moyamoya disease in the acute stage.
    Yu Z; Zheng J; Liu X; Wen D; Guo R; Li M; You C; Li H; Ma L; Yang M
    Clin Neurol Neurosurg; 2019 Sep; 184():105409. PubMed ID: 31302379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and disease progression in moyamoya disease patients with Graves disease.
    Chen JB; Lei D; He M; Sun H; Liu Y; Zhang H; You C; Zhou LX
    J Neurosurg; 2015 Oct; 123(4):848-55. PubMed ID: 25859801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia Is a Predictor for Poor Postoperative Angiogenesis in Adult Patients With Moyamoya Disease.
    He Q; Ge P; Ye X; Liu X; Wang J; Wang R; Zhang Y; Zhang D; Zhao J
    Front Neurol; 2022; 13():902474. PubMed ID: 35720075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Susceptibility Loci for Moyamoya Disease Revealed by a Genome-Wide Association Study.
    Duan L; Wei L; Tian Y; Zhang Z; Hu P; Wei Q; Liu S; Zhang J; Wang Y; Li D; Yang W; Zong R; Xian P; Han C; Bao X; Zhao F; Feng J; Liu W; Cao W; Zhou G; Zhu C; Yu F; Yang W; Meng Y; Wang J; Chen X; Wang Y; Shen B; Zhao B; Wan J; Zhang F; Zhao G; Xu A; Zhang X; Liu J; Zuo X; Wang K
    Stroke; 2018 Jan; 49(1):11-18. PubMed ID: 29273593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of Apolipoprotein-E and Apolipoprotein-J in Moyamoya Disease-A Proteome Analysis of Cerebrospinal Fluid.
    Kashiwazaki D; Uchino H; Kuroda S
    J Stroke Cerebrovasc Dis; 2017 Dec; 26(12):2981-2987. PubMed ID: 28843803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical course of asymptomatic adult moyamoya disease.
    Jo KI; Yeon JY; Hong SC; Kim JS
    Cerebrovasc Dis; 2014; 37(2):94-101. PubMed ID: 24435045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating endothelial progenitor cells as a pathogenetic marker of moyamoya disease.
    Jung KH; Chu K; Lee ST; Park HK; Kim DH; Kim JH; Bahn JJ; Song EC; Kim M; Lee SK; Roh JK
    J Cereb Blood Flow Metab; 2008 Nov; 28(11):1795-803. PubMed ID: 18612318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.
    Lanterna LA; Galliani S; Zangari R; Conti L; Brembilla C; Gritti P; Colleoni ML; Bernucci C
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1194-1199. PubMed ID: 29305275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracranial Aneurysms in Adult Moyamoya Disease.
    Kim JH; Kwon TH; Kim JH; Chong K; Yoon W
    World Neurosurg; 2018 Jan; 109():e175-e182. PubMed ID: 28962951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proximal internal carotid artery stenosis associates with diffuse wall thickening in petrous arterial segment of moyamoya disease patients: a three-dimensional magnetic resonance vessel wall imaging study.
    Chen X; Wang J; Liu Y; Yang Y; Zhou F; Li X; Zhang B; Zhao X
    Neuroradiology; 2019 Jan; 61(1):29-36. PubMed ID: 30402746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.